tiprankstipranks
CanSino Biologics, Inc. Class H (HK:6185)
:6185
Hong Kong Market
6185
CanSino Biologics, Inc. Class H
RESEARCH TOOLSreports

CanSino Biologics, Inc. Class H (6185) Financial Statements

5 Followers

CanSino Biologics, Inc. Class H Financial Overview

CanSino Biologics, Inc. Class H's market cap is currently HK$13.08B. The company's EPS TTM is HK$0.061930653839999995; its P/E ratio is 292.71; CanSino Biologics, Inc. Class H is scheduled to report earnings on March 30, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 1.03B¥ 846.34M¥ 345.18M¥ 1.03B¥ 4.30B
Gross Profit¥ 681.82M¥ 601.91M¥ -876.02M¥ -186.61M¥ 3.00B
Operating Income¥ -113.12M¥ -375.22M¥ -2.04B¥ -1.37B¥ 1.94B
EBITDA¥ 60.98M¥ -134.84M¥ -1.65B¥ -1.32B¥ 1.85B
Net Income¥ 27.15M¥ -378.88M¥ -1.48B¥ -909.43M¥ 1.91B
Balance Sheet
Cash & Short-Term Investments¥ 2.65B¥ 3.20B¥ 4.12B¥ 5.95B¥ 7.78B
Total Assets¥ 7.18B¥ 7.96B¥ 9.32B¥ 11.47B¥ 11.87B
Total Debt¥ 1.29B¥ 2.01B¥ 2.70B¥ 2.70B¥ 1.37B
Net Debt¥ 52.78M¥ 456.91M¥ 653.34M¥ -694.19M¥ -4.08B
Total Liabilities¥ 2.05B¥ 3.05B¥ 4.03B¥ 4.22B¥ 3.33B
Stockholders' Equity¥ 4.96B¥ 4.91B¥ 5.27B¥ 6.75B¥ 8.00B
Cash Flow
Free Cash Flow¥ -152.83M¥ -626.42M¥ -1.53B¥ -2.96B¥ 811.42M
Operating Cash Flow¥ 32.49M¥ -168.79M¥ -916.25M¥ -1.89B¥ 2.01B
Investing Cash Flow¥ 355.36M¥ 3.96M¥ -449.65M¥ -1.19B¥ -2.53B
Financing Cash Flow¥ -703.03M¥ -334.18M¥ -7.58M¥ 854.60M¥ 1.56B
Currency in CNY

CanSino Biologics, Inc. Class H Earnings and Revenue History

Income Statement >

CanSino Biologics, Inc. Class H Debt to Assets

Balance Sheet >

CanSino Biologics, Inc. Class H Cash Flow

Cash Flow >

CanSino Biologics, Inc. Class H Forecast EPS vs Actual EPS

Earnings >